Quest Diagnostics announced that CEO Jim Davis will present the company's strategy, performance, and insights on market trends at the Baird 2026 Global Healthcare Conference in New York on September 15, 2026. The session will include a fireside chat and Q&A, streamed live and archived on the company's investor relations website. This event provides investors and stakeholders a chance to hear directly from leadership about Quest's role in advancing healthcare diagnostics and future outlook. The webcast will remain available until October 13, 2026.
Quest Diagnostics disclosed a cyberattack targeting its Quanum lab testing system, which handles patient test requests and billing. The breach exposed sensitive patient health and billing information, though the exact scope and number of affected rec...
Quest Diagnostics reported a 10% revenue increase to $3.10 billion in Q3 2026, driven by strong organic growth across physician, hospital, and consumer channels. Adjusted EPS rose 15.4% to $3.00, reflecting productivity gains from automation and AI. ...
